NCT06203600 2026-03-17
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
National Cancer Institute (NCI)
Phase 2/3 Recruiting
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
University Health Network, Toronto
Gruppo Oncologico del Nord-Ovest